Respiratory Syncytial Virus (RSV)
- Profiles in Catholicism
- Nov 4, 2022
- 1 min read
Updated: Apr 12, 2024
Medical Journal Articles
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus by Fatimah S. Dawood, MD, Amanda B. Payne, PhD, and Meredith L. McMorrow, MD, MPH JAMA April 11, 2024
Wastewater Surveillance Predicts Large-Scale Flu, RSV Trends by Emily Harris JAMA September 27, 2023
RSV Infection in Older Adults by Kathleen A. Linder, MD, and Preeti N. Malani, MD, MSJ JAMA September 7, 2023’
FDA Approves RSV Monoclonal Antibody for Infants and Young Children by Emily Harris JAMA July 26, 2023
CDC: RSV Vaccine Recommended for Older People by Emily Harris JAMA July 12, 2023
FDA Clears RSV Vaccine for Adults Aged 60 Years or Older by Emily Harris JAMA May 17, 2023
RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials by Emily Harris JAMA April 13, 2023
General Articles/Commentaries
RSV virus in babies, children and adults – symptoms and warning signs by The Independent. Ie
WATCH: “We are confronting extreme climate events” by Alan Rosenbaum The Jerusalem Post
FDA approves RSV injection for infants by Aria Bendix NBC News
RSV virus in babies, children and adults – symptoms and warning signs by The Independent.ie
Europe approves 1st one-dose drug to protect babies against RSV by The Associated Press/PBS
The Worst Pediatric Care Crisis in Decades by The Atlantic/Bioethics.com
RSV hospitalizations shoot up to levels typically seen in December, CDC data shows by Deidre McPhillip CNN